Skip to content

Hyloris Pharmaceuticals

Active Risk: not assessed Public limited companyfounded 2017active for 9 yearsBoulevard de Patience et Beaujonc 3, 4000 LiègeKBO/BCE: BE 0674.494.151 #2 company by equity in the province of Liège, Administrative and support services sector
Hyloris Pharmaceuticals
Follow ReportCompare

Board

7 directors, 1 in day-to-day management, 1 auditor, no change since 2025
Jacobsen Management BV
Director, permanent representative Thomas JACOBSEN
current term since 30-09-2024 term until 13-06-2028
earlier co ceo, until 17-12-2025
also on the board of 5 other companies
listed in the 2025 annual accounts, filed on 07-07-2026
Stefan Yee
Director
current term since 30-09-2024 term until 13-06-2028
listed in the 2025 annual accounts, filed on 07-07-2026
1 other company bankrupt
SVR Management BVBA
Director and seule personne chargée de la gestion journalière, permanent representative Stijn VAN ROMPAY
director current term since 30-09-2024 seule personne chargée de la gestion journalière appointed by deed of 17-12-2025 term until 13-06-2028
listed in the 2025 annual accounts, filed on 07-07-2026
Van Rompay Management SRL
Director, permanent representative Leon Van Rompay
current term since 30-09-2024 term until 13-06-2028
listed in the 2025 annual accounts, filed on 07-07-2026
Biofinance Consulting BV
Independent director, permanent representative Mélanie MESTDAGT
since 10-06-2025 3-year term from 2025
listed in the 2025 annual accounts, filed on 07-07-2026
IRYL Partners SAS
Independent director, permanent representative Revital RATTENBACH
since 10-06-2025 3-year term from 2025
listed in the 2025 annual accounts, filed on 07-07-2026
Sybefica Invest BV
Independent director, permanent representative Vincent VAN DESSEL
since 10-06-2025 3-year term from 2025
listed in the 2025 annual accounts, filed on 07-07-2026
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
Statutory auditor, permanent representative Christophe PELZER
since 10-06-2025 3-year term from 2025
listed in the 2025 annual accounts, filed on 07-07-2026
SVR Management
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“2. décident que, nonobstant les pouvoirs de représentation de la Société à l'égard des tiers prévus dans les statuts de la Société…”
deed of 02-10-2024
Permanent representatives 6
Stijn VAN ROMPAY
Permanent representative, for SVR Management
appointed by deed of 18-02-2020
Thomas JACOBSEN
Permanent representative, for Jacobsen Management
appointed by deed of 18-02-2020
Leon Van Rompay
Permanent representative, for Van Rompay Management SRL
appointed by deed of 08-12-2020
Mélanie MESTDAGT
Permanent representative, for Biofinance Consulting BV
appointed by deed of 21-10-2025
Revital RATTENBACH
Permanent representative, for IRYL Partners SAS
appointed by deed of 21-10-2025
Vincent VAN DESSEL
Permanent representative, for Sybefica Invest BV
appointed by deed of 21-10-2025

Office holders in the KBO →

Mandates through the years

20 names, the dashed line is today
Show
Jacobsen Management
Director
Stefan Yee
Director
SVR Management
Director, Seule personne chargée de la gestion journalière
Van Rompay Management SRL
Director
IRYL Partners SAS
Independent director
Sybefica Invest BV
Independent director
Biofinance Consulting BV
Independent director
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
Statutory auditor
FOIDART Marc
Independent director
Revital RATTENBACH
Independent director
Vincent VAN DESSEL
Independent director
KPMG Bedrijfsrevisoren BV/SRL / KPMG Réviseurs d'Entreprises BV/SRL
Statutory auditor
Pienter Jan BV
Independent director
Carolyn Jane MYERS
Independent director
James Charles GALE
Independent director
NOSHAQ PARTNERS
Independent director
VAN ROMPAY Leon Emiel
Director
GRNR INVEST
Director
Stijn VAN ROMPAY
Director
SVR INVEST
Director
LeadershipBoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
  • Jacobsen Management
    • Director, appointed by deed of 18-02-2020, still in office
    • Managing director, appointed by deed of 02-10-2024, until 17-12-2025
  • Stefan Yee
    • Director, appointed by deed of 18-02-2020, still in office
  • SVR Management
    • Director, appointed by deed of 18-02-2020, still in office
    • Seule personne chargée de la gestion journalière, appointed by deed of 17-12-2025, still in office
  • Van Rompay Management SRL
    • Director, appointed by deed of 08-12-2020, still in office
  • IRYL Partners SAS
    • Independent director, from 30-09-2024 to date
  • Sybefica Invest BV
    • Independent director, from 30-09-2024 to date
  • Biofinance Consulting BV
    • Independent director, from 10-06-2025 to date
  • BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
    • Statutory auditor, from 10-06-2025 to date
  • FOIDART Marc
    • Independent director, appointed by deed of 06-12-2024, until 21-10-2025
  • Revital RATTENBACH
    • Independent director, from 30-09-2024 to 21-10-2025
  • Vincent VAN DESSEL
    • Independent director, from 30-09-2024 to 21-10-2025
  • KPMG Bedrijfsrevisoren BV/SRL / KPMG Réviseurs d'Entreprises BV/SRL
    • Statutory auditor, from 31-12-2019 to 26-09-2025
  • Pienter Jan BV
    • Independent director, appointed by deed of 06-07-2021, until 06-12-2024
    • Independent director, appointed by deed of 06-07-2021, no longer listed in the 2025 annual accounts
  • Carolyn Jane MYERS
    • Independent director, appointed by deed of 08-12-2020, no longer listed in the 2025 annual accounts
  • James Charles GALE
    • Independent director, appointed by deed of 08-12-2020, no longer listed in the 2025 annual accounts
  • NOSHAQ PARTNERS
    • Independent director, appointed by deed of 08-12-2020, no longer listed in the 2025 annual accounts
  • VAN ROMPAY Leon Emiel
    • Director, appointed by deed of 22-04-2020, until 08-12-2020
  • GRNR INVEST
    • Director, until 18-02-2020
  • Stijn VAN ROMPAY
    • Director, until 18-02-2020
  • SVR INVEST
    • Day-to-day manager and managing director, appointed by deed of 08-06-2017, last mentioned in 2017
    • Director, until 18-02-2020

Control

Shareholder
Stijn Van Rompay
7,743,067 voting rights
27.65%
This company
Hyloris Pharmaceuticals
Equity €87.2m
Loss €1.2m in 2025

and 5 other shareholders

Capital

Capital
€140,002
Shares
28,000,374
Contribution per share
€0.01
Equity per share
€3.11 in 2025
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
Stijn Van Rompay
natural person
26.42%27.42%27.65%
27.65%
Thomas Jacobsen
natural person
13.56%13.06%13.78%12.26%
12.26%
SCORPIAUX
6.69%6.17%
6.17%
Nick Reunbrouck
natural person
6.23%5.66%5.75%
5.75%
Pieter Van Rompay
natural person
3.54%3.79%3.27%
3.27%
Dietmar Aichhorn
natural person
0.12%
0.12%
DVP Invest
1%listed0.98%
0.98% until 2024
SAFFELBERG INVESTMENTS
3.19%
3.19% until 2021
Owners as a list

Older annual accounts also name 2 natural persons.

Source: shareholder structure in its own accounts, lists of holdings in the owners' accounts

Articles of association

deed of 22-07-2020 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 3 directors
“4 ans”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Tuesday of June at 14:00

Shareholders

6 owners

Owners 6

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 20-08-2020 ↗
Capital over time
  1. 19-07-2022 Capital increase of €6,000 · to €140,001.87 · 1,200,000 new shares at €2.36 per share · in cash
  2. 25-04-2022 Capital increase · to €134,001.87 · 967,742 new shares at €15.50 per share · in cash
  3. 20-08-2020 Capital increase of €1,200 · to €129,163.16 · 240,000 new shares at €10.75 per share · in cash
  4. 12-08-2020 Capital stated in the deed · €89,008.84 · 17,801,768 shares
  5. 22-07-2020 Capital increase of €10,204.32 · 2,040,864 new shares
  6. 22-07-2020 Capital increase · 5,750,000 new shares · in cash
  7. 18-02-2020 Capital increase of €17,108.18 · to €89,008.84 · 855,409 new shares · in kind
  8. 25-06-2018 Capital increase of €4,974.22 · 248,711 new shares
Show 2 older capital entries
  1. 25-06-2018 Capital increase of €5,426.44 · 271,322 new shares
  2. 07-06-2017 Capital stated in the deed · €61,500 · 3,075,000 shares

The directors' other companies

1 current director with another company that went bankrupt, was dissolved or struck off

1 other company of this director went bankrupt (2025).

Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure